IP Library Granted Patent US 11,944,835
Granted Patent B2
US 11,944,835 · App. 17/378,131 · Granted Apr 2, 2024

Wearable cardioverter defibrillator (WCD) system having WCD mode and also AED mode

Inventors: Brian D. Webster (Sammamish, WA); Zoie R. Engman (Kirkland, WA); Phillip D. Foshee, Jr. (Woodinville, WA); David P. Finch (Bothell, WA); Joseph L Sullivan (Kirkland, WA); Gregory T. Kavounas (Bellevue, WA)
Assignee: West Affum Holdings DAC
A61N1/3904A61N1/046A61N1/0484A61N1/3625A61N1/3918A61N1/3925A61N1/3968A61N1/3987A61N1/3993
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,944,835
App. No.
17/378,131
Granted
Apr 2, 2024
Kind
B2
Abstract

In embodiments, a Wearable Cardioverter Defibrillator (WCD) system includes a support structure for the patient to wear, and components that the support structure maintains on the patient's body. The components include a defibrillator, associated electrodes, and so on. The defibrillator can operate in a WCD mode while the patient wears the support structure. The defibrillator can further operate in a different, AED mode, during which time the patient need not wear a portion of the support structure, or even the entire support structure. Sometimes the AED mode is a type of a fully automatic AED mode. Other times the AED mode is a type of a semi-automated AED mode, where an attendant is present to administer the shock; at such times, the patient may not even need to have electrodes attached. This way the patient is more comfortable for a longer time.

Claims (50)

1. A wearable cardioverter defibrillator (WCD) system for an ambulatory patient, comprising:

a support structure configured to be worn by the ambulatory patient;

a defibrillator configured to be coupled to the support structure; and

a defibrillation electrode, including:

a wire lead that is configured to be coupled to the defibrillator,

a pad having two functional sides comprising a first functional side and a second functional side, and coupled to the wire lead, the pad configured to be coupled to the support structure so that the first functional side of the pad is maintained on a body of the ambulatory patient when the support structure is worn by the ambulatory patient, and

an adhesive material arranged on the second functional side of the pad so that the adhesive material is shielded from contacting the support structure or the body of the ambulatory patient when the first functional side of the pad is maintained on the body of the ambulatory patient when the support structure is worn by the ambulatory patient,

wherein the defibrillation electrode is configured to be manipulated to unshield the adhesive material to allow the second functional side of the pad to be maintained on the body of a person or the ambulatory patient with the adhesive material when the support structure is not worn by the ambulatory patient, and

wherein the pad is configured to apply a therapeutic shock through the first functional side of the pad when the support structure is worn by the ambulatory patient, and through the second functional side of the pad when the support structure is not worn by the ambulatory patient.

2. The WCD system of claim 1 , in which

the defibrillation electrode further includes a plug at an end of the wire lead, the plug configured to be coupled to the defibrillator.

3. The WCD system of claim 1 , in which

the defibrillation electrode further includes a liner attached to the pad via the adhesive material, and

manipulating includes removing the liner from the pad.

4. The WCD system of claim 1 , in which

the defibrillation electrode further includes a backer with an end portion that is folded onto the pad, and

manipulating includes removing the end portion of the backer from the pad.

5. The WCD system of claim 1 , wherein the first functional side of the pad is free of adhesive material.

6. The WCD system of claim 1 , further comprising a liner removably attached to the second functional side of the pad.

7. A method of operating a wearable cardioverter defibrillator (WCD) system that is intended for a patient who is ambulatory, the WCD system including a support structure, a defibrillator, a defibrillation electrode including a wire lead, a pad having a first functional side and a second functional side, and an adhesive material arranged on the second functional side of the pad, the method comprising:

coupling the pad to the support structure when the support structure is worn by the patient with the defibrillator coupled to the support structure, wherein the first functional side of the pad is maintained on a body of the patient, the wire lead is coupled to the pad and to the defibrillator, and the adhesive material is shielded from contacting the support structure or the body of the patient;

manipulating the defibrillation electrode when the patient is not wearing the support structure, wherein the defibrillation electrode is adapted to unshield the adhesive material; and

adhering the pad to a body of a person or a patient using the unshielded adhesive material so that the second functional side of the pad is maintained on the person or the patient when the support structure is not worn by the patient;

applying a therapeutic shock through the first functional side of the pad when the support structure is worn by the patient, and through the second functional side of the pad when the support structure is not worn by the patient.

8. The method of claim 7 , further comprising:

uncoupling the defibrillator from the support structure to deliver the therapeutic shock when the support structure is not worn by the patient.

9. The method of claim 7 , further comprising:

uncoupling the defibrillation electrode from the support structure to deliver the therapeutic shock when the support structure is not worn by the patient.

10. The method of claim 7 , in which

the defibrillation electrode further includes a liner attached to the pad via the adhesive material, and further comprising

removing the liner to at least in part unshield the adhesive material.

11. The method of claim 7 , in which

the defibrillation electrode further includes a backer with an end portion that is folded onto the pad, and further comprising

removing the end portion of the backer to at least in part unshield the adhesive material.

12. The method of claim 7 , wherein the first functional side of the pad is free of adhesive material.

13. A defibrillation electrode, comprising:

a wire lead;

a pad coupled to the wire lead, the pad presenting a first functional conductive surface exposed, and a second functional conductive surface opposite the first functional conductive surface, the first and the second functional conductive surfaces electrically coupled to the wire lead;

an adhesive material on the second functional conductive surface; and

a liner attached to the second functional conductive surface removably via the adhesive material;

wherein the first functional conductive surface is configured to contact a body of a patient, and the second functional conductive surface is configured to be protected from the body of the patient, when the second functional conductive surface is covered by the liner; and

wherein the second functional conductive surface is configured to contact the body of the patient when the liner is removed from the second functional conductive surface.

14. The defibrillation electrode of claim 13 , in which

there is no adhesive material on the first functional conductive surface.

15. The defibrillation electrode of claim 13 , further comprising:

a liner attached to the second functional conductive surface removably via the adhesive material.

16. The defibrillation electrode of claim 13 , in which

the pad is flexible.

17. The defibrillation electrode of claim 16 , in which

there is no adhesive material on the first functional conductive surface.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2025
From: KESTRA MEDICAL TECHNOLOGIES, INC.
To: WEST AFFUM HOLDINGS CORP.
Reel/Frame 070429/0370 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2023
From: FOSHEE, PHILLIP D., JR.; FINCH, DAVID P.; SULLIVAN, JOSEPH L.
To: PHYSIO-CONTROL DEVELOPMENT CO., LLC
Reel/Frame 065928/0173 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2023
From: WEBSTER, BRIAN D.; ENGMAN, ZOIE R.; FOSHEE, PHILLIP DEWEY, JR.; FINCH, DAVID P.; SULLIVAN, JOSEPH L.
To: PHYSIO-CONTROL, INC.
Reel/Frame 065721/0148 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2023
From: KAVOUNAS, GREGORY T.
To: WEST AFFUM HOLDINGS CORP.
Reel/Frame 065721/0301 →
SECURITY AGREEMENT Recorded Oct 4, 2023
From: WEST AFFUM HOLDINGS DESIGNATED ACTIVITY COMPANY
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 065116/0049 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2022
From: WEST AFFUM HOLDINGS CORP.
To: WEST AFFUM HOLDINGS DAC
Reel/Frame 060389/0694 →
Continuity (3)
Continuation 16147450 · Sep 28, 2018
Provisional Application 62584659 · Nov 10, 2017
Related Publication 20210339031A1 · Nov 4, 2021